FNY Investment Advisers’s Nautilus Biotechnolgy NAUT Stock Holding History
Bought
Maintained
Sold
Other funds holding NAUT
ST
HC
CA
YIH
CG
ATPW
PCM
BPWM
PFSRSONJ
TWC
FNY Investment Advisers's NAUT Position: Q2 2026 in Review
FNY Investment Advisers held its Nautilus Biotechnolgy (NAUT) position steady in Q2 2026 at 14,000 shares worth $26K. The position accounts for 0.01% of the portfolio, ranked #498.
FNY Investment Advisers first reported a position in NAUT in Q2 2021 and has held it in 11 quarters since. The position peaked at $137K in Q1 2022. 17 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.
- FNY Investment Advisers held 14,000 shares of Nautilus Biotechnolgy worth $26K as of Q2 2026.
- FNY Investment Advisers left its Nautilus Biotechnolgy share count unchanged in Q2 2026.
- Nautilus Biotechnolgy made up 0.01% of FNY Investment Advisers's portfolio in Q2 2026, its #498 holding.
- FNY Investment Advisers first reported a position in Nautilus Biotechnolgy in Q2 2021 and has held it in 11 quarters since.
- FNY Investment Advisers's Nautilus Biotechnolgy position peaked at $137K in Q1 2022.
- 17 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.
Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.